FEACR/circRNA0008180 was significantly decreased in H/R-treated primary cardiomyocytes, an in vitro model used to mimic I/R injury.
Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia/reperfusion injury by interacting with NAMPT.